2024 Sponsors & Exhibitors

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. To learn more, please visit www.astrazeneca.com

BD Medical – Pharmaceutical Systems provides a broad range of ready-to-use drug delivery systems including glass and plastic prefillable syringes, safety and shielding systems, self-injection systems and connected solutions that help ensure smooth delivery, regardless of drug complexity, viscosity and dosing volume. BD Medical – Pharmaceutical Systems provides pharmaceutical and biotechnology companies with support and resources to help them achieve their goals. We support their product launch and life cycle management through a range of consultative, analytical and clinical services to help ensure drug compatibility and seamless systems integration, while accelerating time-to-market and reducing risk. For more information, visit https://drugdeliverysystems.bd.com/

Phillips-Medisize, a CDMO of drug delivery, diagnostic and medtech devices, provides innovative products and strategy, design, development and manufacturing services to the global industries. We offer complete end-to-end capabilities from early device strategy through design and development, human factors engineering, clinical production to full scale production, including drug handling and finishing. We have a particular focus on drug delivery devices and connected health, and played an integral role in the first FDA approval for a fully connected drug delivery device, with a regulated companion digital service. Based on our track record of device development and manufacture, and responding to market requirements, we have increased our focus on developing platform-based drug delivery devices. These target the markets need for flexible, cost effective, timely solutions that meet both the industries needs and those of the patient. Our platforms include a smart autoinjector, wearable bolus and a large volume injector and a Mini-tablet Dispenser. For more information, visit www.phillipsmedisize.com.

ApiJect™ is a global medical technology company whose products are designed to provide the advantages of prefilled syringes (quality, convenience, safety) at the cost- efficiency of multi-dose formats, regardless of manufacturing volume. Our Platform achieves this by bringing together two trusted manufacturing technologies: Blow-Fill- Seal aseptic filling and high precision injection molding. To learn more, please visit www.apiject.com

Kymanox is a life science professional services organization that offers engineering, scientific, compliance, and project management support to companies exclusively in the biotechnology, pharmaceutical, medical device, and combination product industries. Kymanox helps clients navigate commercialization challenges that arise throughout a product’s life cycle. To learn more, visit www.kymanox.com.

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with expertise in complex oral formulations. Our specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. To learn more, please visit www.adarepharmasolutions.com

Altaviz is the global leader in designing gas-powered delivery systems. Learn how to harness gas-power for delivery of High Viscosity / High-Volume biologics and challenging drug delivery applications with the AltaVISC High Viscosity / High-Volume Auto-Injector; one of a portfolio of Altaviz gas-powered drug / implant delivery technologies. To learn more, please visit www.altaviz.com

Anodyne is a venture-backed clinical stage biotech company simplifying chronic care for every stakeholder. Our proprietary technology, the HeroPatch, enables the delivery of multi-milligram doses of large molecules transdermally. We look to partner to improve clinical outcomes with alternatives to both established and novel therapies. To learn more, please visit https://www.theheropatch.com/

For pharma customers worldwide, Aptar Pharma is the go-to drug delivery expert, from formulation to patient, providing innovative drug delivery systems, components and active material solutions across the widest range of delivery routes. Aptar Digital Health solutions help improve the patient treatment experience and Aptar Pharma Services help accelerate and derisk the drug development journey. To learn more, visit www.aptar.com/pharmaceutical

Archimedic is an ISO 13485 certified contract development organization (CDO) that specializes in drug delivery devices and combination products. With deep experience in prefilled syringes, autoinjectors, infusion pumps, inhalers, and novel delivery technologies, Archimedic helps companies navigate IP landscapes, optimize devices for usability, meet reliability and manufacturing requirements, and ensure that therapeutics and biologics are safely packaged and accurately delivered. Archimedic's team of engineers, researchers, and strategists ensure that pharma companies not only have a robust and user-centered design, but the regulatory and commercial aspects have been addressed at each stage of development. To learn more, please visit https://www.archimedic.com/

Asahi Kasei Corporation (Headquarters: Tokyo, Japan) is the leading manufacturer and supplier of functional pharma excipients, such as microcrystalline cellulose, in Japan. In order to further address the rising demands in formulation research, we are now developing a cutting-edge pharma excipient primarily for injections: hyaluronic acid nanogel, Sonanos™. The Sonanos™ can act as a DDS carrier, facilitating sustained release or solubility enhancement of APIs. For more information, please visit https://www.ceolus.com/en/sonanos/hyaluronic_acid_nanogel/

Ascendia Pharmaceuticals is a specialty CDMO that provides custom formulations and manufacturing. Our experts deliver sophisticated formulations to enhance bioavailability, solubility and stability, while reducing toxicity using GRAS (Generally Regarded As Safe) materials and four proprietary nanotechnologies – NanoSol®, EmulSol®, AmorSol® and LipidSol®. Ascendia offers its manufacturing services to biotech and pharmaceutical companies who seek a CDMO partner for their formulations that is steeped in socratic process as it transitions from a pre-clinical and early clinical development to scale-up, late-stage clinical trials to robust commercial supply. For more information, visit www.ascendiapharma.com.

Battelle combines medical device design and development, formulation expertise and human centric design to create innovative drug delivery systems that condense the development timeline and get our clients’ drugs to market faster. Battelle’s cross-disciplinary teams of experts mitigate risk and cut a clear path to regulatory approval for pharmaceutical companies looking to gain a competitive edge. Learn more at www.battelle.org.

BDD has world leading expertise in the development and clinical testing of innovative pharmaceutical products. Our development strategies are underpinned by our understanding of biopharmaceutics which has evolved over years of experience in visualising in vivo performance of products using gamma scintigraphy. BDD combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products. To learn more, please visit https://www.bddpharma.com/

Bionaut is a micro-robotic CNS drug delivery platform. Conventional CNS drug delivery methods (infusion, intra-thecal) grapple with the blood-brain barrier, yielding low brain concentration, limited efficacy, and systemic side effects. Bionaut is backed by $76M+ in funding from top investors including Khosla, Gates Ventures, Mayo Clinic Ventures, UC Healthcare Ventures and Altitude Ventures, among others. We have two in-house clinical programs and are gearing up for our first clinical program at Mayo Clinic later this year. Bionaut is actively seeking pharma collaborations and licensing opportunities. For more information, visit https://bionautlabs.com/

Biond Biologics is a private, clinical-stage biotech company, developing a pioneering intracellular drug delivery platform called INspire and innovative Immuno-oncology therapies. INspire, delivers biologics, e.g., nanobodies and proteins for intracellular targets considered hard-to-target such as the RAF, RAS proteins. Our IO pipeline includes three novel biological drugs, BND-22 an anti ILT2/LILRB1 antibody, licensed to Sanofi and is in phase 1; BND-35 an anti ILT3/LILRB4, with phase 1 initiating in H1 2024 and BND-67 - A nanobody based agent targeting CD28 shedding potentially effecting resistance to anti-PD-1 therapy. To learn more, please visit https://www.biondbio.com/

Biora Therapeutics is a clinical-stage biotech developing two smart pill-based therapeutics platforms: the NaviCap™ platform for colon-targeted treatment of IBD, designed to improve patient outcomes through treatment at the site of disease in the gastrointestinal tract, and the BioJet™ platform for oral delivery of large molecules, designed to replace injection with needle-free, oral delivery for better management of chronic diseases. For more information, please visit https://www.bioratherapeutics.com/

Biotts S.A. is a pioneering biotechnology start-up based in Poland, dedicated to enhancing global health outcomes through innovative, needle-free transdermal drug delivery systems. Our cutting-edge technology aims to improve the quality of life for millions by enabling the delivery of large-molecule drugs such as insulin without the use of invasive procedures. For more information, please visit https://biotts.com/

Calla Lily Clinical Care is a medical device manufacturer developing the Callavid® vaginal drug delivery platform for a wide range of therapeutics for infertility/miscarriage, gynecological cancers and a healthy vaginal microbiome. To learn more, please visit https://www.callali.ly/

Expand your design possibilities with Celanese engineered materials and support from in-house technical experts. Our high-performance polymers and thermoplastics unlock opportunities for improving patient care with cutting-edge medical and pharmaceutical solutions. Applications include drug delivery, long-acting controlled release delivery, medical devices, orthopedics, advanced surgical instruments, connected devices and more. To learn more, visit http://www.celanese.com/

Our purpose is to optimize the potential of injectable drugs that have emerging and hard-to-address delivery needs. We do this by designing, developing and supplying innovative, flexible drug delivery device platforms. Our growing portfolio addresses compelling problems, including microliter dosing, viscous drug delivery, multi-dosing, variable dosing and minimizing drug waste. To learn more, please visit www.congruencemed.com

Corbion Biomaterials is a leading supplier of GMP-grade bioresorbable polymers used in the creation of long acting injectables (LAIs). Our versatile PURASORB® portfolio provides enabling functionality used by our partners in the design and formulation of innovative therapies, releasing APIs over specific time periods, from weeks to years. Our unique quality-by-design approach also allows our partners to de-risk and accelerate their product development. To learn more, please visit https://www.corbion.com/

Crux was founded to address challenging technical briefs and deliver compelling solutions for the drug delivery and medical device sectors. Based in Bristol, United Kingdom, our technical team champion evidence-based problem solving, coupling world-class equipment, software and facilities with a scientific approach to maximise success. Be it discovering unmet user needs, developing novel products or deploying new technologies, our team are dedicated to solving our client’s biggest problems. To learn more, visit www.cruxproductdesign.com

Dara Pharma designs, develops, and manufactures washing, sterilizing, filling, freeze-drying, and closing machines for vials, bottles, syringes, cartridges, and IV Bags to process liquid, semi-solid products, and powders in sterile conditions.

Dara Pharma provides the pharmaceutical, biotech and cosmetic industries with the most advanced technological equipment in the market, contributing to the improvement of the well-being and quality of life of people. For more information, please go to https://www.dara-pharma.com/en

Datwyler provides high-quality, system-critical elastomer components and has a leading position in the global healthcare market. Within the healthcare solutions business area, Datwyler develops, designs, and manufactures solutions for injectable packaging and drug delivery systems to facilitate customers to create a safer medical environment of tomorrow. Looking back onto more than 100 years of history, Datwyler is a reliable partner, now and in the future! To learn more, please visit https://healthcare.datwyler.com/ 

DelAQUA Pharmaceuticals has developed a breakthrough drug formulation platform that makes it possible to (a) increase solubility of poorly soluble drugs up to 100,000-fold, making them more bioavailable and easier to deliver, (b) co-formulate 2 or more poorly soluble drugs in defined ratios in the same aqueous solution, improving therapeutic outcomes in vivo, and c) easily optimize the excipient chemistry and design to match the properties of the compounds of interest, maximizing drug loading up to 50% or more. Our mission is to hasten the successful formulation and development of therapies that address the unmet medical needs of patients in a broad spectrum of diseases.We are looking for additional partnering, licensing and development opportunities for our own development projects and yours. For more information, visit https://www.delaquapharma.com/

DFE Pharma, a world leader in providing essential excipients for inhalation and oral solid dose applications for decades, has expanded its presence into the biopharmaceutical market. In addition, we offer a purification step integrated into manufacturing process to enhance the product quality and consistency, strengthening supply chain security as product quality is not affect ed by raw material variations. For more information, visit https://dfepharma.com/

DigiM provides microstructure characterization of pharmaceutical materials using high-resolution 3D micro-imaging and analysis. Our image-enabled quantification and simulations facilitate mechanistic understandings of release performance. Our analysis includes porosity, crystallinity, component distributions and sizes, and release profiles. We service long-acting parenterals and sustained-release microspheres, and a variety of non-injectable delivery technologies. Learn more at www.digimsolution.com.

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive.

In the Biomedical division, the company serves as a committed partner in driving sustainable innovation in healthcare, from spark to solution. dsm-firmenich's biomaterial products, customized solutions and expert services are recognized for their unmatched quality, reliability, and performance worldwide.

Together, we bring progress to life™ every day, everywhere, for billions of people. For more information, please visit https://www.dsm.com/biomedical/en_US/home.html

EdgeOne Medical is the Contract Development Organization that specializes in supporting device development and testing programs for combination products for 10 of the top 20 global pharma and the companies they acquire. Utilizing their proprietary EdgeOne Labs and their proven Edgineering method, EdgeOne Medical is considered to be the most technically advanced and reliable partner for ensuring device programs overcome challenges, get on the market and stay on the market. To learn more, please visit www.edgeonemedical.com

Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company headquartered in Canada, with offices in the USA and UK. Entos leverages its proprietary Fusogenix™ platform in its own drug development programs and multiple licenses with pharmaceutical companies. Most recently, Entos partnered with Lilly to develop CNS and PNS-targeted genetic therapies. Learn more at www.entospharma.com

Envoya Inc. is a pioneering biotechnology company specializing in the development of non-lipid polymer-based nanoparticles for gene delivery. Leveraging cutting-edge research and innovative technology, Envoya has successfully crafted nanoparticles that stand out due to their exceptional safety and efficacy profiles. Envoya Inc. is at the forefront of a transformative wave in gene therapy, offering solutions that promise to overcome some of the most persistent challenges in the field. Their innovative use of FDA-approved, non-lipid polymers to create non-immunogenic nanoparticles with high payload encapsulation and transfection efficacy represents a significant leap forward. With a firm commitment to excellence and innovation, Envoya Inc. is poised to make a substantial impact on the future of medicine, bringing forth new possibilities for personalized and effective gene-based treatments. For more information, visit https://www.envoyabio.com/

The Epitomee Oral Delivery of Biologics Platform enables the delivery of large amounts of hard-to-deliver biologics with enhanced bioavailability. Our innovative drug delivery system is designed to transport drugs to the small intestine and through the GI wall, achieving effective bioavailability. For more information, please visit https://epitomeemedical.com/

Evonik Industries, a global leader in specialty chemicals, provides drug delivery technologies, API manufacturing, intermediates, ingredients for nutraceuticals, amino acids and derivatives. Drug delivery technologies include modified release formulation development services, solubility enhancement, functional excipients, bioresorbable polymers, lipid nanoparticle mRNA delivery, and GMP manufacturing for oral and parenteral formulations. Advanced delivery technologies for extended-release parenterals are offered for small molecules, peptides, proteins, antibodies, and nucleic acids. Learn more about us at www.evonik.com/healthcare.

Through the collective strength of a global workforce across 30 countries and responsible, sustainable operations, Flex delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets. Flex’s health solutions business focuses on medical device and drug delivery design, development and manufacturing solutions for pharmaceutical and medtech companies, including extensive work in injection pens, autoinjectors, wearable pumps and smart inhalers. Our approach is supported by FDA-registered and ISO 13485 compliant and ISO 11608-1 accredited facilities, with a world-class single quality system across sites. For more information, visit www.flex.com

FreeThink Technologies is a science-based company conducting experimental work to help clients develop drug products. FreeThink has specific expertise in stability (shelf life) and formulation development and licenses its advanced accelerated stability software ASAPprime®. FreeThink also produces OzmoCAP® extended-release capsules providing a range of release durations, independent of drug properties. To learn more, please visit https://freethinktech.com/

G2GBIO is a clinical-stage biotech company specializing in long-acting injectables of various small molecule and peptide drugs. Its proprietary platform technology, InnoLAMP, enables the mass production of homogeneous microsphere with high drug loading (~60% for small molecules and ~50% for for peptides), improved bioavailability, and less injection site reactions.

Safer Solutions for a more Sustainable World. To learn more, please visit https://www.gaylordchemical.com/

GSK is a global biopharma company with a special purpose – to unite science, technology, and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organization where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030. To learn more, please visit https://www.gsk.com/en-gb/

Haselmeier, the drug delivery device business of medmix, designs, develops and manufactures advanced drug delivery systems, such as pen injection systems and autoinjectors since more than 100 years. With its broad portfolio of technologies and services, Haselmeier delivers user-friendly injection systems that enable patients to self- administer their medication reliably and accurately. Haselmeier is known for its excellent and long-standing track record of providing these innovative drug delivery devices based on its proprietary IP business model. The company collaborates closely with its customers in the pharmaceutical and biopharmaceutical industries. Medmix, with its precision injection molding capabilities and expertise in liquid micro-dosing, plus financial strength and global footprint, helps Haselmeier accelerate innovation in healthcare. For more information, visit www.haselmeier.com

InnoCore Pharmaceuticals is a biopharmaceutical drug delivery company specialized in the development of complex parenteral sustained release formulations. By using our proprietary biodegradable polymers we can make microspheres, erodible gels and solid implants resulting in long acting and minimally invasive drug delivery products of small, medium sized (peptides) and large (proteins, antibodies) drug molecules. Learn more at www.innocorepharma.com.

InnoMedica is a ground-breaking Swiss biotech with the mission to enhance therapies for diseases with great unmet therapeutic needs through further development and new applications of our patented nanotechnology. Our nanotechnology platform is based on particularly small and uniform liposomes with an intelligent surface structure, making medical use of the body's natural logistics for the distribution of molecules. This allows the packaging of active ingredients which cannot reach the target in sufficient quantities or cause severe side effects when applied in high dosages. InnoMedica has applied our proprietary delivery platform to develop treatments for diseases and conditions in different therapeutic areas, with the objective of significantly improving the standard of care for patients with unmet needs.  For more information, visit https://innomedica.com/en/

Isometric’s highly specialized competencies and talents in 3D Micro Printing, Micro Tooling, Micro Molding, Micro Automated Assembly, and CT Scanning provide our customers with a full service of in-house capabilities. From initial concept to high volume production, your project is managed by a team that has designed, built, processed and produced your parts and assemblies for numerous high precision markets. To learn more, please visit www.isomicro.com

At Jabil, we are proud to be a trusted partner for the world's top brands, offering comprehensive engineering, manufacturing, and supply chain solutions. With over 50 years of experience across industries and a vast network of over 100 sites worldwide, Jabil combines global reach with local expertise to deliver both scalable and customized solutions. Our commitment extends beyond business success as we strive to build sustainable processes that minimize environmental impact and foster vibrant and diverse communities around the globe. Discover more at www.jabil.com.

Kano Therapeutics is a biotech company that focuses on developing genetic medicines using circular single-stranded DNA templates. Their work is aimed at expanding the scope and efficiency of gene editing and therapy to targeted kilobase-long genomic insertions. The company collaborates with experts in non-viral delivery methods to enhance the delivery and efficacy of their therapies. For more information, please visit www.kanotherapeutics.com

Key Tech is an end-to-end product development firm specializing in the design of complex electromechanical devices and systems for medical applications. It is 100% employee owned and located in downtown Baltimore (MD, US). Key Tech employs 75 engineers and designers focused on transforming complex technologies into simple, intuitive solutions. For more information, please visit https://www.keytechinc.com/

Nothing is easy when it comes to developing and manufacturing drug delivery systems. But our extensive knowledge, steadfast spirit, and inventive character mean we have navigated endless challenges to bring a wealth of firsts, innovations, and successes to pharmaceutical and biotech drug-delivery initiatives. Kindeva’s MTS platform provides elegant microneedle-based delivery devices, refined and suited to our partners’ programs. From early-phase feasibility to final design requirements, we can meet the needs of challenging drug formulations. Refined over several device generations, Kindeva’s microstructured systems are designed for consistent intradermal delivery of vaccines and biologics. Our patient-friendly technology is available in two formats, providing an option of delivery routes to enable your commercial success. With sophisticated project management, rigorous quality processes, manufacturing excellence, and cGMP facilities, Kindeva supports a reliable supply chain for your program. For more information, visit https://kindevadd.com/

KORU designs and manufactures easy-to-use infusion systems for large volume therapies (10+ ml). Our proven, preferred Freedom Infusion Systems consist of two syringe driver options to accommodate a variety of syringes, tubing and subQ needles. Let us assist with the planning and execution of your large volume subcutaneous drug delivery! To learn more, please visit www.korumedical.com

Lifecore Biomedical is an integrated CDMO with expertise in specialty formulation, aseptic filling, and final packaging of complex medical devices and injectable pharmaceuticals. Capabilities include: FDA-approved commercial products, highly viscous products (in excess of 100,000 cP), process development, clinical and commercial manufacturing, on-site analytical services, and pharmaceutical-grade sodium hyaluronate production. To learn more, please visit https://www.lifecore.com/

Likarda has pioneered a groundbreaking platform for hydrogel delivery systems, offering both long- and short-term solutions that can either provide complete immune-protection or degrade gradually. This innovation enables precise localized therapy delivery without the need for immunosuppression, effectively addressing critical gaps in cell therapy, gene therapy, and drug delivery. To learn more, please visit https://likarda.com/ 

Lipoid is a major international supplier of phospholipids for usage as pharmaceutical excipients. We have a strong focus on quality. Our products are GMP, many have Drug Master Files, and many are utilized in commercial drug products. Lipoid is also known for its expertise in bulk production. This allows us to keep prices affordable and allows you to use identical material in both your first small scale preclinical batch and your future commercial batches. Phospholipids are most known for their use in parenteral applications, such as injectable emulsions and liposomes. They are also excellent excipients in oral, pulmonary, and topical applications, among others. In these applications they improve the bioavailability, solubility, and permeability. For more information, visit https://lipoid.com/en/

MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. compliance with medical prescriptions, and to a significant reduction in the quantity of medication required as part of a one-off or chronic treatment. The BEPO® technology makes it possible to control and guarantee the regular delivery of a drug at the optimal therapeutic dose for several days, weeks or months starting from the subcutaneous or local injection of a simple deposit of a few millimeters, fully bioresorbable. Based in Montpellier, MedinCell currently employs more than 155 people representing over 30 different nationalities. For more information, visit https://www.medincell.com/

Sparked by scientific breakthroughs in genomic research, Mercury Bio is developing a next-generation biomolecular drug delivery platform. RNA and small-molecule drugs can be delivered by our platform through highly specific cell targeting without creating an immune reaction. Our platform will allow drug developers to speed their products to market by reducing the obstacles and risks encountered by traditional drug delivery systems. Low cost, speed to market, and high targeting will, most importantly, dramatically improve patient outcomes. To learn more, please visit https://www.mercurybio.com/

Merxin Ltd: We Make Inhalers. We make dry powder inhalers (DPI) and soft mist inhalers (SMI). Our range of soft mist, dry powder and multidose dry powder inhalers are ready to launch your molecules. Our capsule DPI MRX003 is on the market; our SMI MRX004 is the preferred option for both biologics and ultra-low carbon footprint; MRX006 is a multidose “open-inhaler-close” DPI; MRX002 is a see through cannister for HFA/HFO pMDI formulations. We Will Launch You. For more information, please visit www.MERXIN.com. 

MilliporeSigma, a life science leader, is a business of Merck KGaA, Darmstadt, Germany. We provide excipients, APIs, and critical raw material as well as contract testing, development and manufacturing services to support all stages of your drug manufacturing process. Benefit from application know-how and global support. To learn more, please visit https://www.sigmaaldrich.com/

Modular Medical is a medical technology company focused on improving insulin delivery systems. Its flagship product, the MODD1, is a user-friendly insulin patch pump designed to be more accessible, affordable, and simpler for both patients and healthcare providers. FDA-cleared for use with insulin-dependent Type 1 and Type 2 diabetics, MODD1 aims to enhance the daily management of diabetes with an easier-to-prescribe and more cost-effective solution. For more information, please visit https://www.modular-medical.com/

PharmaShell® is Nanexa’s novel drug delivery system. PharmaShell® achieves a high drug load, low injection volume, with excellent in-situ stability, controlled burst release and depot length. This is achieved by formulating a suspension containing coated drug particles with a controlled solubility of the coating. As the coating dissolves, the drug is released in a pre-defined manner over time. To learn more, visit https://nanexa.com/

Incorporated in 2003, Nanobiotix is headquartered in Paris, France and has been listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge, Massachusetts (United States) amongst other locations. Nanobiotix has created three nanophysics-based technology platforms with multiple product applications: 1) nano-radioenhancers to help millions of patients receiving radiotherapy; 2) nanoprimers to overcome challenges with liver clearance and redefine the way drugs can be designed bioavailability; and 3) nanoparticles for disorders of the central and peripheral nervous system. For more information, visit www.nanobiotix.com

Nanomol Technologies is a science and innovation driven company offering novel nanoformulation solutions by our patent protected, green and robust DELOS technology, in addition to advanced cGMP particle characterization services. DELOS nanocarriers stabilize, protect and improve the performance of APIs -from small chemical molecules to biologics, including peptides, proteins and nucleic acids (miRNA, siRNA, DNA), of interest of our partners, enabling new administration routes and enhanced or novel drug products. We work with our partners to unlock pharmaceutical R&D, generating high quality nanomedicines that reach clinical phases: Reformulating drug candidates with poor solubility, bioavailability or stability Obtaining tailored multifunctional drug delivery systems that overcome cell barriers and reach specific tissues. For more information, visit https://nanomol-tech.com/

NanoViricides, Inc. is a clinical stage company creating novel nanomaterials called “nanoviricides™” to cure viral infections. Oral NV-387 is in Phase 1a/1b for COVID and also has demonstrated broad-spectrum activity against multiple other viruses including RSV. Our safe nanomaterials can be receptor-targeted to deliver API cargo to specific cells. Our own multi-Kg-scale cGMP-compliant manufacturing facility has capabilities for making API and Drug Products (formulation, fill, finish, label, packaging). To learn more visit www.nanoviricides.com

NOF CORPORATION is the leading commercial supplier of drug delivery products such as activated PEGs, lipids and ultrapure Polysorbates 80. Our cutting edge products include Pendant type single molecule PEG linkers for ADCs and SS-lipids for nucleic acid and gene delivery. For more information, visit www.nofamerica.com

Nutcracker Therapeutics is an RNA therapeutics company that has combined advanced engineering with high-precision biosynthesis to deploy a platform that encompasses the design, delivery and manufacturing of RNA medicines. The company has initiated therapeutic programs with the support of clinical investigators at leading institutions. Its platform has the potential to reduce costs and cycle times with advantages in speed and capacity scaling over other manufacturing approaches. To learn more, please visit https://www.nutcrackerx.com/

Oakwood Labs specializes in the development and aseptic manufacturing of sustained-release microsphere products, ranging in duration from weeks to one year, through the use of our patented Chroniject™ technology. Oakwood’s FDA approved cGMP aseptic facility enables partners the ability to bring products from feasibility concepts to successful commercialization. To learn more, visit https://oakwoodlabs.com/

OncoLize develops injectable drug depots for localized, intra-tumoral drug-delivery. The company demonstrates precision: 125x higher drug concentration at target, much smaller doses in total, very low drug levels outside the tumor… Strong pre-clinical P-o-C with 100% survival in vivo with pancreatic-cancer and lung-cancer. Raising €2.5 to finalize pre-clinical early 2025; Series A of €10-15 mln early 2026. Next: Lung, Colon, Breast, Bladder, Prostate.  To learn more, please visit https://oncolize.com/

Oxford Medical Products (OMP) is a UK-based biotech that has developed a gastroretentive, hydrogel platform technology. The technology is currently in phase 2 trials as a stand-alone anti-obesity treatment and is also being developed as an oral drug delivery system for both small molecules and peptides. The technology may overcome common oral delivery challenges, such as poor bioavailability and high peak-to-trough ratios, by facilitating sustained release from the stomach. Notably, the technology is ideally suited to delivering cardiometabolic drugs due to its inherent appetite-suppressing capabilities. The technology is also applicable to stomach-targeted and stomach-absorbed drugs due to prolonged gastric retention and gastric mucosal contact. For more information, visit https://www.oxfordmedicalproducts.com/

OxSonics is a pioneering clinical-stage company on a mission to transform cancer treatment with its breakthrough SonoTran® technology, utilising Innovative proprietary sonosensitive particles, co-administered with anti-cancer drugs, and “activated” by a novel ultrasound device. This enhances the delivery of oncology drugs into solid tumours, improving efficacy and/or reducing off-target toxicity. To learn more please visit: https://oxsonics.com/

pacDNA LLC is revolutionizing oligonucleotide therapeutics through our groundbreaking Brushield™ oligonucleotide delivery technology. With Brushield™, we have unlocked the potential to rapidly develop potent clinical leads with significantly reduced side effects and dosage requirements. Our platform enables delivery to non-liver sites, enhances treatment durability, and minimizes toxicity/immunogenicity. To discover more about our transformative approach, visit www.pacdnatx.com

To help you seize the opportunity of patient-centric drug delivery devices, we’ve built on more than 40 years’ experience designing, developing, manufacturing and commercialising drug delivery systems, from auto-injectors to inhalers to connected systems. We combine this experience with our world-class digital, AI and data development and implementation capabilities, providing you with practical, realistic and achievable recommendations, to help you unlock the full potential of drug delivery systems in the new era of connected health. For more information, please visit https://www.paconsulting.com/industries/life-sciences/pharma-and-biotech/drug-delivery

PCI is a leading global CDMO, providing integrated end-to-end drug development, manufacturing and packaging solutions, increasing product speed to market and commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the delivery of supply chain pharmaceutical services. With 30 sites globally, our mission is to collaborate with our clients and deliver life-changing therapies to patients. To learn more, please visit https://pci.com/

Pendant Biosciences is an advanced materials biotech developing a proprietary biodegradable polymer technology utilizing cross-linked pendant functionalized polymers. This next-generation polymer system overcomes many of the limitations of older PLGA-based systems, is highly tunable and creates innovative long-acting injectable formulations for systemic and localized delivery. To learn more visit https://pendantbio.com/

Our goal is to accelerate pre-clinical development time for long-acting injectables through automation and machine learning. This reduces time-to-market for our pharma customers and enables them to improve patient compliance & quality-of-life. Persist is currently seeking collaborators who’d like a formulation for their API, as a case-study. To learn more, please visit https://www.persist-ai.com/

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more information, visit www.pfizer.com

PharmaCircle is a thought leader in drug delivery and formulation development, publishing the Drug Delivery & Formulation Newsletter, which has a worldwide readership, and in depth reports on all areas of drug delivery, including new and novel technologies and devices. PharmaCircle is also a leading information provider to the pharmaceutical industry, providing business prospecting and analysis tools, pipeline and products intelligence, regulatory data, and other information solutions to our clients. PharmaCircle’s Premium database service delivers a comprehensive view into drug, biologics and combination product development and innovation, combining scientific, clinical, safety, regulatory, supply chain, and commercial data and insights into one solution. For more information, visit www.pharmacircle.com

Pharma Latch is developing a series of healthcare professional and self-administered intradermal injection devices based on an innovative angled needle platform technology. We are funded through venture capital, and more recently by West Pharmaceutical Services. Our first product, the Pharma Latch Hollow (PLH), is currently under development as a sterile-packed, single-use medical device (Class II, FDA 510(k) pathway) and is in late-stage manufacturing in the USA. The PLH is ready for use in pre-clinical studies now (in small or large animals) with clinical evaluation planned for 2025. A series of self-injector devices, composed of the same core platform technology are also under development. For more information, visit https://www.pharmalatch.com/

Phosphorex, Inc is considered the leader in sustained release drug delivery with over 10 years of experience in microsphere-based platform technologies and products. Phosphorex offers tailored solutions and enabling technologies to optimize a drug’s release rate, targeting ability, and bioavailability, thereby achieving desired therapeutic effects while reducing adverse clinical outcomes. Our custom drug delivery solutions enable sustained release, targeted delivery, and solubility enhancement and include drug encapsulation in microspheres and nanoparticles, solid dispersion, micronization and nanosizing. We support all stages of drug development from proof of concept to clinical trials. For more information, visit www.phosphorex.com

Piezo Therapeutics aims to transform the delivery of nucleic acid medicines to enable improved safety, efficacy, affordability, and scalability. Piezo is developing a uniquely engineered platform that uses electric pulses and microneedles to deliver a broad range of therapeutics inside the body and is simple, cost-effective, and rapid to produce at scale. To learn more please visit: www.piezotx.com

Portal is transforming medicine by allowing chronic patients to self-inject their biological drugs with a needle-free device. This innovative drug delivery system replaces auto-injectors and is overwhelmingly patient preferred. Issued from MIT Research and easily connected to the cloud, the Portal device allows biopharmaceutical companies to augment their biological therapies and differentiate them from competitors. The device captures injection data in real time and transmits those via the cloud to all stakeholders for optimal care. Portal’s business model is to partner with biopharmaceutical companies and co-develop drug/device combination products. The company has partnerships with Takeda Pharmaceuticals, Sanofi SA and 3M. To learn more, visit www.portalinstruments.com

PSN Labs is your full-service partner for engineering and product development, specializing in drug delivery solutions. From concept to commercialization, we manage every step, ensuring risk mitigation and optimization through virtual and physical processes. Our ISO 17025 Testing Lab offers biocompatibility testing, drug stability assessments, and regulatory consulting. With ISO 13485-certified molding facilities equipped with cleanroom capabilities, we streamline manufacturing and functional prototyping. Consolidating services with PSN Labs saves time, costs, and ensures the highest quality standards are met, providing a hassle-free experience for our clients. For more information, visit https://www.psnlabs.com/

Re-Vana Therapeutics is a Transformative Ocular Therapeutics company, developing Sustained Release 6 Months+ Biologics with our proprietary biodegradable photo crosslinked technologies. To learn more, please visit https://www.revanatx.com/

ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. ReCode’s SORT LNPs are engineered with a biochemically distinct fifth lipid to help the body “sort” and direct the LNPs to other targeted organs such as the lung and spleen with the ability to bypass the liver, if desired. For more information, visit www.recodetx.com and follow us on Twitter @ReCodeTx and LinkedIn.

Rommelag Engineering’s BLOW-FILL-SEAL ADVANCED ASEPTIC LIQUID PACKAGING is the world leader in the manufacture of the filling machines. Achieve unparalleled flexibility, heightened performance, and uncompromising safety—all housed in the industry's most compact design. Packaging solutions with its bottelpack® Blow/Fill/Seal technology in plastic containers in a wide range of sizes and shapes that are formed, filled, and sealed within a single step, avoiding the need for pre-formed containers. We offer are machine construction and sales as well as CDMO services. For more information, visit https://www.rommelag.com

Sail Biomedicines, a Flagship Pioneering company, is generating tomorrow’s medicines today through the language of life. Sail’s platform combines first-in-category translatable circular RNA technology (Endless RNA™ or eRNA™), and proprietary programmable nanoparticles, utilizing natural components, to comprehensively program medicines for the first time. By leveraging its rapid prototyping and testing bioplatform, Sail is building a wealth of data, enabling unparalleled use of state-of-the-art AI techniques for the integrative design of RNA medicines with unprecedented performance and broad applicability. For more information, visit  https://www.sail.bio/

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

Sanofi’s mRNA Center of Excellence (CoE) pursues the development of new mRNA vaccine candidates to address the long-standing challenges in cancer, immune-mediated diseases, and rare diseases, focusing on thermostability and tolerability. For more information, visit www.sanofi.com

Secant Group, a global biomaterials leader, offers an innovative controlled active release technology platform Hydralese™, a bioresorbable polymer that enables sustained drug delivery via surface erosion. Specializing in formulation and development services for a variety of API’s and finished dosage forms including implantable rods and microspheres, we have the expertise to support pharmaceutical customers seeking to improve patient compliance and healthcare globally. Learn more at www.secant.com/hydralese

Serán is a sci­ence-based CDMO that specializes in a variety of drug delivery and formu­lation strategies suited to optimizing bioavailability. Serán’s experienced formulation team works with customers to identify an appropriate formulation strategy to meet each program’s unique needs with a material-sparing approach. Serán provides capsules, tablets, multi-particulates, and PiB formulations. To learn more, please visit https://www.seranbio.com/

As the pioneering leader in self-injection solutions, SHL Medical works with leading pharmaceutical and biotechnology companies to design, develop, and manufacture patient-centric drug delivery systems that support home-based treatments with combination products. Our products include autoinjectors, pen injectors, and innovative specialty delivery systems for large-volume and high-viscosity drug formulations. To learn more, please visit https://www.shl-medical.com/

SMC Ltd. Group provides “end-to-end” integrated services for clinical and commercial manufacturing of drug delivery combination products. Oval Medical specializes in the development of patient-centric autoinjectors for challenging drug formulations including high viscosity/high volumes. Visit us at www.smcltd.com and/or www.ovalmedical.com

SonoThera is pioneering the future of genetic medicine with our groundbreaking ultrasound-guided, redosable, non-viral gene therapy platform. We offer a revolutionary approach to genetic therapies, enabling precise, non-invasive delivery of diverse genetic payloads—including large and complex formats like DNA and RNA—across virtually any organ in the body. Based in South San Francisco, SonoThera secured $60 million in Series A funding with ARCH as lead in late 2022. As we advance our pipeline of research and pre-clinical programs, we are poised to initiate our first clinical trials in 2025, setting the stage for a new era in genetic medicine. For more information, visit https://sonothera.com/

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients. For more information, visit www.stevanatogroup.com

Suntec Medical is a biotech innovator transforming cancer and CNS disease therapies with its MINC technology. MINC can deliver biologics to the brain at 100-1000x higher dosages with high efficacy and safety. Our lead drugs, STM-001 for glioma and STM-003 for Alzheimer’s, are entering Phase I/IIa trials in Q3/2024 and Q2/2025. Our portfolio includes treatments for Parkinson’s and other neural diseases. Discover more about our groundbreaking work at https://suntecmedical.com/

Surf Bio is a preclinical biopharmaceutical company that is transforming how antibodies and biologics are delivered to patients. Surf SnapShot™ technology enables mAb concentrations of 600+ mg/mL and delivery of a dose over 1,000 mg in a single, standard autoinjector shot. SnapShot’s™ ultra-high concentration formulations are uniquely powered by Surf Bio’s proprietary polymer, enabling the most accessible and patient-friendly subcutaneous delivery of mAbs and biologics. To learn more, please visit https://www.surf.bio/

Suttons Creek is pharma’s device team. Any life sciences company going to market with a drug delivery system needs a device team experienced in combination products working alongside their drug team. That device team includes specialists in areas like quality, regulatory, vendor selection and management, systems engineering, risk management, clinical development, human factors, and commercialization. Suttons Creek has over 650 years of combined experience and 120+ combination product projects under its belt. Our talent pool of subject matter experts specializes in all device-related aspects of the combination product lifecycle, from strategic planning through development to launch and postmarket activities. Our history of success proves that hiring our experienced device team results in faster time to market, reduced risk, improved patient experience and adherece, and lower overall cost (higher profit). For more information, visit https://suttonscreek.com/

Team Consulting is a world-class partner in medical device design and development. Working with leading pharma companies to innovative start-ups, we apply the latest approaches in design theory, engineering ingenuity and human factors to create user-centered solutions for your drug delivery needs. For more information visit https://www.team-consulting.com/

As Part of Terumo Medical Care Solutions, the Pharmaceutical Solutions Division develops patient-oriented parenteral delivery solutions for therapeutic performance and safety. Globally trusted for quality and precision, we offer pharmaceutical and medical device manufacturers around the world comprehensive product design and development services. We have decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral drug delivery. Innovation and creativity are central to our value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies, including CDMO services for all parenteral applications. We listen. We question. We deliver. For more information, visit https://www.terumopharmaceuticalsolutions.com/

Founded in 2016 and headquartered in Maryland, U.S., Theradaptive is a venture-backed, clinical-stage biopharmaceutical and medical device company. The company aims to leverage its therapeutic delivery platform to precisely deliver biologics to targeted areas of the body with high local precision, persistence, and potency, addressing significant medical needs. Theradaptive’s protein engineering platform allows therapeutic molecules to be "painted" onto implants, ensuring localized and sustained therapy without systemic side effects. The novel technology supports the development of new therapies in spine, orthopedics, soft tissue repair, and targeted immuno-oncology. Theradaptive's spinal fusion product, OsteoAdapt SP, recently secured IDE Approval from the FDA to begin clinical trials, opening a new chapter in Theradaptive's growth as a clinical-stage company. To learn more, please visit https://www.theradaptive.com/.

Torramics is an injectable drug delivery company applying silicon technology for administration over days in an on-body device the size of 2 stacked quarters. Deliveries range from a 50nL cycle to 300 mL/hr with 1% standard error, detecting occlusions, air or leaks in real time. Applications are insulin and GLP-1s. To learn more, please visitwww.torramics.com

Triastek, Inc. is a global healthcare company, developing medicines with proprietary, pioneering 3D printing technology called Melt-Extrusion Deposition (MED®). Triastek is dedicated to revolutionizing the delivery, development and manufacturing of pharmaceutical products by unlocking the next generation of medicine through the use of 3D printing technology. To learn more visit https://www.triastek.com/

Trust Bio-sonics, based in Taiwan, is a global leader in microsphere technologies for contrast-enhanced ultrasound imaging and ultrasound-mediated drug delivery. The company focuses on cardiovascular diseases and cancer, striving to offer early diagnosis and treatment solutions for patients. Trust Bio-sonics' leading diagnostic ultrasound imaging candidate, TBS-002 (a 505b1 New Drug), has commenced Phase 3 trials under the supervision of both the US FDA and Taiwan FDA. The company is also leveraging TBS-002's technology in combination with portable ultrasound to create a platform, TBS-602, for drug delivery and efficacy enhancement in pancreatic cancer treatment and other oncology applications. This platform has been shown to improve the effectiveness of conventional small-molecule chemotherapy drugs and large-molecule immunosuppressants, such as anti-PD-L1 immunotherapy. For more information, visit https://www.trust-biosonics.com/en-us/

TTP is a product development consultancy that has been helping pharma and medical device companies develop new, innovative and marketable drug delivery solutions for over 30 years. This experience encompasses a broad range of respiratory, parenteral and transdermal devices. To learn more, visit https://www.ttp.com/

Vesselon develops drug co-formulations using an FDA-approved, biophysically activated lipid microsphere. These co-formulations safely make targeted tissues more receptive to therapeutic drugs, producing unprecedented levels of efficacy. Our third-generation oncolytic adenovirus has been shown to produce far greater CD8+ infiltrates as well as tumor necrosis with our IV microsphere delivery system than intratumoral injections. To learn more please visit www.vesselon.com.

Vetter is a leading fill and finish CDMO headquartered in Ravensburg, Germany. Pharmaceutical and biotech companies worldwide rely on Vetter's decades of experience, high quality, and state-of-the-art technologies. Vetter provides support from drug product development through clinical and commercial filling to a wide range of assembly and packaging services for various injection systems. With innovative solutions, Vetter develops prefilled drug delivery systems and processes to continuously improve patient safety, comfort, and compliance. To learn more, please visit https://www.vetter-pharma.com

Vivani Medical is an emerging biopharmaceutical company aiming to make chronic disease treatments easier, more convenient, and potentially more tolerable, by developing miniature, ultra long-acting subdermal implants designed to address medication non-adherence. Vivani’s initial focus is on GLP-1 treatment for obesity and type 2 diabetes. Learn more at vivani.com.

West is a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable medicines. We are a trusted partner to the world’s top pharmaceutical and biotechnology companies—working by their side to improve patient healthTo learn more, visit https://www.westpharma.com/

Windgap Medical is imagining the future of reconstitution devices. Our autoinjector platforms simplify, automate, and speed up the delivery of difficult-to-mix drugs, freeing patients, families, and potential cures from the limitations of current medical delivery technology. We are a proud industry leader in self-administration devices that consider the needs of patients first when delivering complex injectables. To learn more, visit https://windgapmedical.com/

Ypsomed is the leading developer and manufacturer of self-injection solutions with over 35 years of experience. With our modular and proven platform products we are the preferred partner of pharmaceutical and biotech companies for pens, autoinjectors, patch-injectors and smart devices integrated into digital therapy management systems. To learn more, visit www.ypsomed.com

Zephyrus Innovations (Zephyrus) is a privately-owned medical device company designing safety syringes and Closed System Transfer Devices (CSTDs), based in Vancouver, Canada. Zephyrus has developed the world’s 1st CSTD for Sub-Cutaneous and Intra-Muscular Injection to supplement an already FDA-cleared auto-retractable syringe.

Zerion Pharma A/S is a pharmaceutical company aspiring to transform the pharmaceutical landscape for the formulation of poorly soluble drugs that are currently not reaching their therapeutic potential.

The company was established in 2019 as a spinout from the University of Copenhagen based on a decade of research. Zerion Pharma A/S has pioneered the Dispersome® technology that greatly enhances the solubility of poorly soluble, oral drugs and improves bioavailability and therapeutic options for patients. Zerion Pharma A/S develops proprietary drug formulations and offers the Dispersome®technology to established pharma companies as a means to solve their most challenging drug solubility problems. Through the use of our proprietary Dispersome® formulation platform, we aim to develop new treatment options for patients across all small molecule therapy areas, striving to improve the lives of patients around the world. For more information, visit https://www.zerion.eu/

Antares Health Products Inc. (Antares) is leading supplier of vitamin E TPGS, a powerful tool in the formulation of pharmaceuticals, dietary supplements, food and beverage, personal care, and animal nutrition and health products. Antares produces TPGS in a manufacturing facility that meets current Good Manufacturing Practices (cGMP). The Antares Team combines proven, strong and diverse expertise in the manufacturing and applications of TPGS. Our Team works in close partnership with customers to meet their needs with high-quality product coupled with full technical support and customer service. For more information, visit https://www.tpgs.com/

Biograil has developed a proprietary oral delivery technology called BIONDD™ (pronounced BEYOND). The technology fits into a standard size (00 or 0) capsule effectively delivering the active substance to the systemic circulation. Biograil team members were R&D responsible for developing the world’s first FDA approved injection molded tablet. To learn more, please visit: https://biograil.com/

Bryllan LLC is a fill finish CMO focused on supporting the product life cycle of complex drug and device combinations. Bryllans core competency is to solve complex filling problems. Enhanced formulation science combined with device innovation provides a platform for the development of more complex drug delivery and Bryllan is uniquely positioned to support this need with flexible and scalable fill finish capacity. Bryllan currently offers development and clinical supply in syringes, cartridges and IV Bags and is actively pursuing commercial scale fill-finish capacity for liquid-liquid and powder-liquid syringe and cartridge formats to provide significant commercial volumes. For more information, visit www.Bryllan.com

About Croda’s Pharma business – www.crodapharma.com Croda’s Pharma business is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations, committed to enabling the next generation of drug delivery systems. The business is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein, and nucleic acid, delivery platforms.

For over a decade, Eitan Medical has provided safe, intuitive, and flexible infusion solutions that meet evolving drug delivery needs. Eitan Medical's product lines include the Sapphire™ infusion platform, providing connected infusion therapy systems in hospital and ambulatory settings, Avoset™ infusion pump, connected infusion systems focusing on the specialty infusion market, and Eitan Insights™, a cloud-based software platform, designed to transform infusion management. For more information, visit https://eitanmedical.com/

Elcam Drug Delivery Devices (E3D) is a subsidiary of Elcam Medical, an Israel-based group with 40 years of experience in the development, manufacturing, and global distribution of medical devices.E3D is focused on the design, development, manufacturing, and supply of injectable drug delivery devices for self-administration and use in non-clinical environments. Its broad technology portfolio encompasses devices suitable for drugs in a range of primary containers - including auto-injectors, on-body delivery systems, and smart devices with wireless connectivity. For more information, visit https://elcam3d.com/

Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The company offers a comprehensive portfolio of pharmaceutical primary packaging, drug delivery systems and digital solutions. Gerresheimer ensures that medicines reach patients safely and can be administered reliably. With around 12,000 employees and 35 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for the regional markets with a focus on the pharma industry. For more information, visit www.gerresheimer.com

Liberate Bio aims to achieve the extraordinary—delivering genetic medicines that transcend liver-based limitations, liberating patients from disease. The full potential of genetic medicines will be unlocked using generative artificial intelligence trained on high-quality, in vivo data to accelerate every aspect of creating novel, extrahepatic vehicles. Precise Delivery. Boundless Impact. For more information visit: www.liberatebio.com

Ligandal delivers molecules precisely where they need to go. Using flexibly manufacturable, organ- and tissue-specific peptide ligands, their rapid and predictive, payload- and target-agnostic platform enables personalized, precision, and preventative medicine through delivery of nucleic acids, proteins, and molecular materials. Powered by LigandAI® and Predictive Interactomics®. For more information, visit https://api.ligandal.com/

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast. For more information, please visit https://www.quotientsciences.com/

Seaport-based Satio is radically improving the workflow of healthcare to allow it to decentralize while providing improved outcomes and broader, more equitable access. The two areas of focus are drug and vaccine delivery and on-board in vitro diagnostics. The origin of Satio and KKR Sapphiros traces to founder Namal Nawana, former CEO of Alere and of Smith & Nephew, who continues to pursue the passion he developed for decentralizing care of the highest quality prior to selling Alere to Abbott. https://satiopatch.com/news/

At Thermo Fisher Scientific, our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics, or the development and manufacture of life-changing therapies, we are here to support. To learn more, visit thermofisher.com.

Uneedle is a pioneering company specializing in the design and manufacturing of silicon microneedles for intradermal and suprachoroidal injections. With ISO13485 certification, we leverage advanced semiconductor manufacturing processes to deliver precise, atom-sharp needles, ideal for applications ranging from vaccine delivery to ophthalmic treatments. Our microneedles enable more efficient drug delivery, reduce patient discomfort, and are compatible with standard medical devices. Uneedle's innovative platform is CE-marked, FDA-approved, and supports pharmaceutical partners in co-developing novel therapies, ensuring scalability and superior performance. Based in the Netherlands, we bring the best of high-tech, GMP-compliant cleanroom production to healthcare innovation. To learn more, please visit https://www.uneedle.com/

3P innovation is a UK-based custom automation company supporting pharma and medical device businesses to develop new products, devices and novel production processes. 3P innovation specialises in aseptic processing and powder/liquid filling technologies, designing and building scalable GMP production solutions, from lab-scale/bench-top machines through to commercial-scale lines. To learn more, please visit www.3pinnovation.com

AdhereTech is revolutionizing clinical trial adherence with its innovative Aidia System. Unlike traditional methods such as pill counting, journals, or video capture, our patented smart cap technology provides unparalleled accuracy in medication adherence tracking while minimizing patient burden. We address the critical need for increasing medication adherence, helping biotech and pharma companies maximize effect size and demonstrate efficacy. Our solution overcomes limitations of current offerings and doesn’t require additional stability testing. By partnering with AdhereTech, clinical operations teams ensure regulatory compliance, optimize drug accountability, and can avoid significant financial and operational consequences of failed trials due to non-adherence. For more information, please visit https://adheretech.com/

Established in 2004, Agno Pharma is a leading global CDMO headquartered in Bethlehem, PA, USA. Specializing in comprehensive cGMP manufacturing solutions, we excel in developing and producing regulatory starting materials (RSMs), intermediates, and active pharmaceutical ingredients (APIs). Our capabilities include high potent, sterile, and flow-based APIs, along with complex sterile drug product formulations such as injectable suspensions, emulsions, long-acting implants, and other implantable products. To learn more, please visit http://www.agnopharma.com/

Ardena is a fully integrated CDMO with a core focus on bringing molecules to the clinics. Our services include: Small-molecule API projects, spanning route scouting, development, and accelerated manufacturing, including HPAPI; Phase-appropriate drug product development and manufacturing, bioavailability enhancement expertise and HPAPI and controlled substances capabilities; Packaging and logistics for clinical trials; Expert CMC regulatory support; Leading nanomedicine development and manufacturing services; Comprehensive bioanalytical expertise. To learn more, please visit https://ardena.com/

Argonaut Manufacturing Services is a leading contract development and manufacturing organization (CDMO) dedicated to supporting biopharmaceutical and combination product innovators with high quality GMP manufacturing services in the areas of formulation, aseptic fill/finish, kitting, device assembly, and distribution. Argonaut’s Aseptic Drug Product Fill/Finish facility is designed for clients in pre-clinical through commercial phase. Find out more by visiting https://www.argonautms.com

For drug delivery devices, Artcraft Health is creating a new reality around errorless demonstration devices and training. We call it Certainty of Use. In addition to developing medical demonstration devices and training materials, we’ve launched a proprietary technology for device onboarding that eliminates 100% of user errors across all training sessions. To learn more, please visit www.artcrafthealth.com.

ARx custom develops and manufactures transdermal patches and oral/transmucosal thin film delivery systems for unique drug delivery and patient needs. Our drug delivery technologies expand delivery possibilities for active pharmaceutical ingredients with tailored drug delivery profiles that meet the therapeutic needs of the patient with rapid onset or controlled release, all while enhancing compliance, bioavailability, and avoiding adverse events associated with the 1st pass metabolism. We partner to improve drug delivery at any stage in drug development, from product concept & feasibility assessment through commercial production.

At our ISO13485 certified medical division BAUMANN addresses the unique needs of customers in the medical and pharmaceutical industry. BAUMANN has the know-how to tackle the specific challenges, extraordinary standards, and strict requirements of the industry, and stand as recognized expert. To learn more, visit http://www.baumann-medical.com/

Covestro is one of the world's leading manufacturers of high-quality polymer materials and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. For applications such as medication delivery, surgical instruments, electromedical equipment and wound care, Covestro offers dedicated thermoplastics, films, TPU, raw materials for adhesives, foams, and more. For more information, please visit https://solutions.covestro.com/en/industries/healthcare

DCA is one of the world’s leading product design consultancies, with an exceptional record of developing drug delivery devices from strategy, through technical delivery, to market success. We can provide expert support for device strategy, due diligence, mechanical engineering, connectivity, medical device software, electronics, usability, industrial design, industrialisation support, packaging and instruction design. To learn more, visit https://www.dca-design.com/

EMIT Imaging offers Cryo-Fluorescence Tomography (CFT) instrumentation and services, enabling a transformative 3D approach to analyze whole-animal therapeutic distribution and protein expression. Our imaging platform, XerraTM, provides high resolution and sensitivity imaging for improved visualization of multiplexed whole-body distribution and delivery, co-localization of drug with targets, and on/off target tissue identification. For more information, contact https://emitimaging.com/.

Grand River Aseptic Manufacturing, Inc. (“GRAM”) is a leading contract development and manufacturing organization with advanced equipment and innovative technology that delivers customized solutions to meet clients’ fill and finish needs for liquid vials, lyophilized vials, syringes, and cartridges. With biologic, small molecule, and vaccine capabilities, Grand River Aseptic Manufacturing supports pharmaceutical development, cGMP manufacturing, analytical testing, and regulatory filing. To learn more, please visit https://www.grandriverasepticmfg.com/

H&T Presspart is a world leader and specialist in the design, development and manufacture of drug delivery devices and pharmaceutical components. With 50 years’ experience in partnering with the world’s leading pharma companies we have developed a strong reputation for precision and reliability – critically important when patients’ quality of life depends on our products. To learn more visit www.presspart.com

Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise. The systematically structured portfolio of upscalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production. For more information, visit https://hoefliger.com/en/

For over 75 years, we have been delivering high precision injection molds for some of the most successful metered dose inhalers, insulin pens, diagnostic products and other medical drug delivery devices around the world. Our problem-solving mindset, proven track record in the healthcare industry, considerable medical experience and meticulously methodical way of working ensures you the highest quality, process control and traceability needed for your medical products. To learn more, visit www.igsgebojagema.nl

Our 30 years of experience (GLP/GCP/GMP) in the development of complex dosage forms helps to drive our partner’s programs forward daily. With specialist expertise in orally inhaled & nasal drug product development (OINDPs), we provide analytical testing integrated with formulation and clinical manufacturing capabilities, to support a wide range of projects. Our expertise covers small and large molecules - where we have a dedicated facility for biologics characterisation - and selecting the right delivery platform and device technology to suit your needs. Our expert analytical services include specific aerosol testing for OINDPs, as well as characterisation and QC testing for various classes of molecules, including DNA therapies, peptides, cell & gene therapies, liposomes, nanoparticles and vaccines. We can also run E&L studies and provide regulatory services through our network of laboratories and consultants. For more information, visit https://www.intertek.com/pharmaceutical/melbourn/

Joymed Technology is a leading Contract Development and Manufacturing Organization (CDMO) in the medical device industry, dedicated to providing comprehensive research and development, clinical trial, regulatory approval, and contract manufacturing services for global medical device companies and clinical institutions.

For more information, please visit https://www.joymedtech.com/

Kinneir Dufort is a design and development consultancy focused on creating value through tomorrow’s delivery systems and devices. Combining expertise in engineering, user-experience and digital, we support companies globally to improve patient adherence through customized device and packaging solutions. Our experience across the entire development process helps address new challenges, deliver on business outcomes, and create user experiences that drive demand. To learn more, please visit www.kinneirdufort.com

Lesjöfors manufactures and supplies the medical industry with springs and pressings from wire or strip material for disposable medical products, medical equipment and hygiene-related products. We have an expansive network of production plants around the world with exceptional expertise and equipment dedicated to the medical sector. Regardless of the quantity and application, we offer innovative solutions for manufacturing, cleanliness, packaging and automation. Our medical technological high-quality standards are achieved through state-of-the-art production facilities and production technology, a large range of products, use of the latest laboratory technology and certified standards. For more information, please visit https://www.lesjoforsab.com/industries/medical/

We CARE. We CREATE. We DELIVER. The driving philosophy behind LTS LOHMANN Therapie-Systeme AG. As a trusted technology partner for the pharmaceutical industry, we develop and manufacture innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) as well as wearable drug delivery devices (“OBDS”). LTS´ commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 40 development projects targeting multiple disease indications. LTS’s innovation pipeline contains both partner-funded and proprietary, LTS-funded projects. With its SorrelTM wearable drug delivery platform LTS offers patient friendly solutions for complex drugs delivery at home. For more information, visit www.ltslohmann.com

Lyophilization Technology, Inc. is a Contract Development and Manufacturing Organization. The company conducts applied research, provides comprehensive scientific services and technical support ranging from developing new freeze-dried products and processes, streamlining operations to improving compliance, and manufactures clinical supplies for freeze dried pharmaceuticals, biologics, diagnostics, biopharmaceuticals and fine chemicals. To learn more, please visit https://www.lyotechnology.com/

A global provider of healthcare manufacturing solutions, MGS provides the right balance to drive vital innovations: robust, vertically integrated global capabilities combined with the strong customer focus and seamless collaboration of an agile partner. That’s why we’re the global healthcare manufacturing partner of choice for today’s leading Pharma, Diagnostic and MedTech companies. For more Information, please visit https://www.mgsmfg.com/

Mikron Automation is your worldwide partner for advanced assembly solutions. At Mikron we are committed to delivering the best assembly systems and all needed services throughout your product’s entire life cycle. With our extensive engineering know-how, complex process expertise, scalable platforms and lifelong support we are driving lasting success for your business. To learn more, visit www.mikron.com

Millstone Medical is a leading CDMO providing end-to-end solutions for combination device & drug packaging, assembly, testing and distribution. Founded in 2000 and headquartered in Massachusetts, Millstone Medical is your single source solution for clinical trials of combination products and speed to market. Our ISO 13485 dedicated class 7 clean rooms, innovative technology and skilled teams will guide your device from development to market. Our certified laboratories provide product, packaging and environmental testing to our biopharmaceutical customers 60% faster than industry norms. To learn more, please visit www.millstonemedical.com.

German CDMO operating in biotech and pharmaceuticals fields with core expertise in nanotechnologies & particle engineering. Our R&D labs and cGMP-manufacturing site provide end to end solutions from concept to clinical batch manufacturing including development, transfer and GMP production of nano- and microparticle formulations. We also provide Quality Control, Batch release and Stability studies. To learn more, please visit https://mybiotech.de/

Noble is the global leader in medical device training solutions, patient onboarding strategies, and user-centered solutions for the world’s top pharmaceutical brands. Our mission is centered on how we can better Ideate. Validate. Educate ™ and bring the voice of the patient into our research, design, and develop of innovative products and services that provide value to our clients. For more information, visit https://www.gonoble.com/

Noxilizer is a fast-growing medical technology company that provides ultra-low temperature nitrogen dioxide sterilization that offers many benefits over traditional sterilization methods. Our customers are the leading global pharmaceutical, biotech and medical device companies developing the next generation of products. Noxilizer products and services include: feasibility studies, contract sterilization, consulting, sterilization equipment, consumable product line, and customer and technical service. Noxilizer’s headquarters are in Hanover, MD. To learn more, please visit https://noxilizer.com/

OnDosis is an AstraZeneca spinout addressing individualized and connected treatments through its proprietary drug delivery technology for oral solid drugs. The technology enables precise and flexible dosing in the patient’s home environment through a connected handheld device with associated digital solution, also supporting adherence and remote patient monitoring. To learn more, visit https://www.ondosis.com/

With more than 70 years’ experience in medical devices, Owen Mumford Pharmaceutical Services is a division of Owen Mumford, with the Head Office located in Woodstock, UK. Our global presence spans from manufacturing facilities in the UK and Malaysia to subsidiaries in the US, Germany and France. Owen Mumford Pharmaceutical Services specializes in the design, development and manufacture of injectable drug delivery systems for the pharmaceutical, biotech and generics industries. Our trusted devices are used daily in the delivery of various medications for a multitude of conditions across the globe. Our product portfolio includes single and multi-dose reusable and disposable auto-injectors, pens, and syringes for subcutaneous and intramuscular administration. Our flagship products include UniSafe® platform, a spring-free, passive safety device for 1ml and 2.25ml pre-filled syringes. UniSafe 1mL has regulatory approval as a combination product in Asia and Europe where it is also in patient use. Our most recent innovation is the 2-step disposable auto-injector Aidaptus®. Aidaptus can be used for both 1mL and 2.25mL syringes in the same base device. It can also readily adapt to different fill volumes using auto-adjust plunger technology providing a solution for formulation changes during development and lifecycle management. We are proud to have been awarded a distinction in the prestigious Red Dot awards for innovative product design 2023 for Aidaptus. For more information, visit https://www.ompharmaservices.com/

Paragon Medical serves as your strategic partner in medical device manufacturing, offering an end-to-end supply chain solution from product development, to verification and validation testing, to final production, assembly, and ongoing strategic demand planning. Discover how you can experience a consistently remarkable partnership through Paragon Medical’s differentiated and personalized solutions. To learn more, please visit www.paragonmedical.com

Picocyl is the global leader for developing medical grade gas-power components. Discover how to harness gas-power using Pico-Cylinder power to design challenging drug and implant delivery systems for High Viscosity / High-Volume biologic drug delivery. The customer Picocyl Gas-Powered Test Kit will be on display. To learn more, please visit www.picocyl.com

Pyramid Labs provides contract development, manufacturing and analytical services for parenteral drugs. From pre-clinical development to commercial supply and regulatory support, our expertise has enabled multiple clients to develop and launch their biologics, peptide and small molecule drugs. For more information, go to https://www.pyramidlabs.com/

At RPK Medical, we stand out as your long-term partner, experts in crafting tailor-made solutions in the medical device sector. Our commitment goes beyond providing solutions – we aim to transform lives for the better. We prioritize listening to you, understanding your unique needs, and tailoring solutions that go beyond springs, stamping & bending or assemblies with precision and reliability. • 50 years of expertise in creating precision customized parts for security applications • Glocal service: thinking globally, acting locally. Factories in Europe, North America and Asia • Engineering excellence, tailor made for your needs • Customized cleaning and packaging (Clean rooms in Europe, North America and Asia) • A sustainable project, your long-term partner from design to manufacturing. For more information, visit https://rpk-medical.com/en or https://rpk-global.com/medical

RYCHIGER, AG - an innovative high-end technology solution provider at the forefront of LifeScience, IVDx, Drug delivery and Pharma Manufacturing. Developing manufacturing equipment, based on highly modular and scalable systems starting with concept studies, to semi-automatic lab-scale, through to fully automated high volume production lines. For more information, please visit https://www.rychiger.com/industries/life-science

The Sanner Group is a global Contract Development and Manufacturing Organization (CDMO), dedicated to delivering high-quality, finished drug delivery devices for its customers. With over 750 employees and cutting-edge manufacturing facilities across the EU, US, and China, Sanner Group excels in turning complex medical device projects into reality. Their expertise extends across a wide range of critical drug delivery systems, such as autoinjectors, infusion pumps, inhalers, safety syringes, and connected devices. The company's innovative approach to device design and development is further strengthened by its Design Centres of Excellence in the US (Gilero) and UK (Springboard), which drive cutting-edge solutions for customers. For more information, visit https://www.sanner-group.com/

Scherdel Medtech is a family owned, leading global, metal component solutions provider for the medical device and drug delivery markets. We don’t just provide solutions, we provide care. To learn more, visit https://www.scherdel.com/?lang=en

SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. The portfolio comprises drug containment and delivery solutions for injectable drugs ranging from prefillable glass and polymer syringes, to cartridges, vials, and ampoules. To learn more, please visit www.schott-pharma.com

Shaily is a leading manufacturer specializing in the design and manufacturing of high-quality pens and autoinjectors for the pharmaceutical and medical device sectors. Our state-of-the-art manufacturing facilities are equipped with cutting-edge technology and automation, ensuring the highest standards of quality, reliability, and safety in every product we produce. We adhere to the ISO 15378 and 13485 Medical Device Single Audit Program (MDSP) Quality Management System (QMS) which demonstrates our dedication to maintaining rigorous quality control throughout our entire process and supports its customers with DMF, NDA, ANDA, and 510k filings from design and development to production and post-market activities. For more information, visit https://www.shaily.com/

Founded in 2018, Shenzhen CoinCell Battery Co., Ltd. is a lithium-ion battery solution company specializing in R&D, production, and sales of high-performance lithium-ion batteries. We mainly focus on micro lithium-ion batteries, including button type, needle type and others. Our batteries are widely used in wireless Bluetooth earphones, TWS earphones, headset, hearing aid, medical devices, intelligent wearable as well as various electronic devices. We are the first one to develop the super small battery 5853 (5.8*5.3mm diameter*height) and launched successfully. With annual output of more than 160million lithium-ion micro batteries at top safety performance & high energy density, factory’s production capacity is at first class level. All factory production equipment are highly automated and independently designed by us. All battery design and production process are patented. Products have high yield rate and strong competitive advantage. In addition, factory’s laboratories have same safety and reliability test standard with UL & IEC lab. Our standard batteries already applied UL and IEC certificates. For more information, visit https://www.coincell.cn/

SiCare Bio is enabling the next generation of nano-therapeutics through a novel drug delivery platform. Underpinning our platform are precision, nanoporous silicon dioxide particles, which we use to deliver extended and targeted-release therapies. For extended-release delivery, APIs are loaded into our nanoporous microparticles. Each particle is configured for a specific molecule and release profile. Our targeted-delivery system utilizes nano-sized nanoporous particles with high-loading efficiency to deliver payloads for direct cytosolic release.

Smithers helps combination product and pharmaceutical device manufacturers bring innovative, compliant and highly effective products to market with our world-class expertise and extensive testing capabilities. Smithers can assist throughout your product development cycle, from concept, material selection, design for manufacture, manufacture, and packaging, through distribution testing for supply chain validation. To learn more, please visit: https://www.smithers.com

The unique application know-how and experience of the SOTAX Pharma Services team helps pharmaceutical companies worldwide in overcoming the various challenges associated with dissolution and release testing from pharmaceutical dosage forms. Specialized in in vitro dissolution testing, our team has a proven track record of finding the most suitable method for products ranging from APIs and tablets to implants, semi solids, and many more. Set in a US FDA-inspected facility, with a cGMP-compliant environment with strict quality management processes, the scientific expertise of our staff paired with state-of-the-art instrumentation ensures best in class services and ease of regulatory compliance for our customers. For more information, visit www.sotax.us

TxSphere (“Tech Sphere”) was founded as a spin-off of Intuvie LLC to focus exclusively on the development and technology licensing of drug delivery devices for drug-device combination products. Our company’s foundation is built on our extensive experience with infusion pumps and combination drug delivery devices. Our flagship product is the Horizon III, a reusable wearable micro-pump. The disposable component includes a pre-fillable drug reservoir combined with a micro cannula insertion system. The Horizon III is capable of comfortably delivering high volume viscous biologicals, as well as small volumes. For more information, please visit www.tx2sphere.com.

Weidmann Medical Technology AG is an independent swiss injection molding company serving the medical device and pharma industry. Its capabilities include automation, assembly and packaging; industrialisation and scale-up; quality control via in-line camera systems; high-volume plastic consumables. It has production sites with clean-room ISO Classes 7/8 in Switzerland and Mexico. To learn more, visit https://www.weidmann-medical.com/en/

ClostraBio is a spin-out of the University of Chicago focused on developing a novel nanoparticle platform to deliver small molecules to the lower gut. Our polymeric oral prodrug platform was initially designed to overcome challenges with dosing the short-chain fatty acid butyrate. Following a pre-IND meeting with FDA and completion of 28-day toxicology studies showing the polymer backbone is safe, we have now synthesized polymers that release other SCFAs, non-SCFA bacterial metabolites, and other non-metabolite small molecules. We are currently seeking partners interested in utilizing our oral nanoparticle prodrug approach to enable gut-targeted delivery, sustained release, and soluble dosage forms, while creating opportunities to extend patent life. For more information, visit https://clostrabio.com/index.html.

Fzata’s vision is to be the world leader in oral biologics. We have captured the “holy grail” of oral biologics with our first-in-class live Bioengineered Probiotic Yeast Medicines (BioPYMTM) Platform. Our mission is to transform patient safety, efficacy & access to biologics with BioPYM. NIH has vetted and validated our platform; designating Fzata as an NIH Seed Company with over $27MM in grants. Fzata is also honored to be a Startup Stadium Finalist at BIO2024.

We are raising a $10M series A to support manufacturing, pipeline activities and G&A. We are also seeking pharma partners for our lead assets and/or a pilot program. For more information, please visit https://www.fzata.com/

Mana.bio aims to unlock RNA therapy by developing a novel AI-based RNA delivery platform. By utilizing high throughput screening and AI, Mana created a highly efficient, ex-liver cell-specific non-viral RNA delivery solution. Mana built predictive AI models and achieved novel IP-protected in vivo results, including lung-specific delivery of mRNA.

Olfera harnesses the neuro-olfactory epithelium to develop life-changing treatments for brain diseases. Our platform enables effective delivery of therapeutic modalities to the brain and facilitates the discovery of novel drugs for neurodegenerative conditions. To learn more, please visit https://olferatx.com/

Portal is a cell engineering platform company enabling next generation cell engineering and cell analytics across research and clinical applications. The company is implementing a simplified intracellular delivery approach, accelerating advances enabled by the new generation of RNA, gene editing, and molecular design technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. For more information, please visit www.portal.bio

QurCan Therapeutics, a University of Toronto spin-off biotech company, has developed a novel hybrid polymer-lipid nanoparticle technology called TERP platform, that enables non-immunogenic and CNS delivery of RNA molecules. QurCan is leveraging this disruptive TERP nanoparticle technology to advance innovative nucleotide therapeutics for individuals affected by genetically driven neurodegenerative diseases. For more information, please visit www.qurcan.com

RNhale is revolutionizing the pharmaceutical landscape by developing a unique platform technology for formulating RNA-loaded lipid nanoparticles (LNPs) as an inhalable dry powder. This disruptive approach synergizes technological and pharmaceutical strategies to create a novel therapeutic formulation with significant advantages over common LNP-RNA delivery methods. The target is pulmonary diseases with vast addressable markets and undeniable medical needs. For more information, please visit https://www.rnhale.com

SOLUtion Medical is a specialty pharmaceutical company with a fully integrated supply chain for reconstitution products. Our proprietary delivery device portfolio affords patients, caregivers, and clinicians device options to fit within their lifestyles at home and in multiple healthcare settings. For more information, please visit https://www.solutionmedco.com